Elaine Sanij

8PUBLICATIONS
36CO-AUTHORS
Genome structure and regulationRadiation therapyHaematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 23, 2026
RAD54L coordinates the nucleolar DNA damage response to maintain rDNA stability.

|Aug 14, 2025
Ribosome Biogenesis and Function in Cancer: From Mechanisms to Therapy.

Kezia Gitareja, Shalini S Chelliah, Elaine Sanij

|Mar 08, 2024
ERG and c-MYC regulate a critical gene network in BCR::ABL1-driven B cell acute lymphoblastic leukemia.

Kira Behrens, Natalie Brajanovski, Zhen Xu

|Aug 20, 2021
CX-5461 Sensitizes DNA Damage Repair-proficient Castrate-resistant Prostate Cancer to PARP Inhibition.

Mitchell G Lawrence, Laura H Porter, Nicholas Choo

|Nov 25, 2020
CX-5461 can destabilize replication forks in PARP inhibitor-resistant models of ovarian cancer.

Jiachen Xuan, Richard B Pearson, Elaine Sanij

|Nov 11, 2020
The RNA polymerase I transcription inhibitor CX-5461 cooperates with topoisomerase 1 inhibition by enhancing the DNA damage response in homologous recombination-proficient high-grade serous ovarian cancer.

Shunfei Yan, Jiachen Xuan, Natalie Brajanovski

Pageof 2

Frequent Collaborators

4 joint publications

Keefe T Chan

4 joint publications

Richard B Pearson

3 joint publications

Carleen Cullinane

3 joint publications

Jian Kang